Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology DiseasesStrategic Collaboration Agreement • January 9th, 2020
Contract Type FiledJanuary 9th, 2020• Almirall expands its innovation strategy in medical dermatology including therapeutic bispecific antibodies research and development
Strategic Collaboration Agreement for Multiple Bispecific Antibodies Targeting Dermatology DiseasesStrategic Collaboration Agreement • January 9th, 2020
Contract Type FiledJanuary 9th, 2020• Almirall expands its innovation strategy in medical dermatology including therapeutic bispecific antibodies research and development